Weird that people make can mount an argument for selling based...

Weird that people make can mount an argument for selling based on price action and no news.

This is biotech, an industry characterised by long periods of no news and the binary outcomes that rocket or tank the share price. The rest is just noise. The tech is de-risked here and the fundamentals haven't changed contrary to what some are stating above (based on nothing). Adoption takes a long time in the biotech space. As mentioned above, if you don't have the stomach for long waits and extreme volatility, you're investing in the wrong sector.

As an update to my chart, clearly (ad unfortunately) the reverse head and shoulders didn't pan out.

Of note, 85c is a key point of support representing both initial resistance on the first run up in Jan, and the 50% retracement level from recent ($1.48) highs.



If it starts sinking below this point I'd maybe be more concerned, but this stock is very thinly traded with very little free float (again, contrary to wild claims made above) and now showing extremely oversold. A little break above 89c and I would expect a reversal. MACD has now crossed over to a strong buy signal so I would expect near term price action more likely to be positive than negative.